000 | 01977 a2200589 4500 | ||
---|---|---|---|
005 | 20250517230738.0 | ||
264 | 0 | _c20190513 | |
008 | 201905s 0 0 eng d | ||
022 | _a1546-170X | ||
024 | 7 |
_a10.1038/s41591-018-0125-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMadiraju, Anila K | |
245 | 0 | 0 |
_aMetformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. _h[electronic resource] |
260 |
_bNature medicine _c09 2018 |
||
300 |
_a1384-1394 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetyl-CoA Carboxylase _xmetabolism |
650 | 0 | 4 |
_aAdenylate Kinase _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 |
_aDihydroxyacetone _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGluconeogenesis _xdrug effects |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetformin _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aPyruvic Acid _xmetabolism |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStreptozocin |
700 | 1 | _aQiu, Yang | |
700 | 1 | _aPerry, Rachel J | |
700 | 1 | _aRahimi, Yasmeen | |
700 | 1 | _aZhang, Xian-Man | |
700 | 1 | _aZhang, Dongyan | |
700 | 1 | _aCamporez, João-Paulo G | |
700 | 1 | _aCline, Gary W | |
700 | 1 | _aButrico, Gina M | |
700 | 1 | _aKemp, Bruce E | |
700 | 1 | _aCasals, Gregori | |
700 | 1 | _aSteinberg, Gregory R | |
700 | 1 | _aVatner, Daniel F | |
700 | 1 | _aPetersen, Kitt F | |
700 | 1 | _aShulman, Gerald I | |
773 | 0 |
_tNature medicine _gvol. 24 _gno. 9 _gp. 1384-1394 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41591-018-0125-4 _zAvailable from publisher's website |
999 |
_c28661885 _d28661885 |